Unified Patent Court (UPC) analytics are now available. Check here

Get Patent Opposition Report for Janssen Pharmaceutica

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Janssen Pharmaceutica against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3291679Altering Microbial Populations & Modifying MicrobiotaSNIPRSep 14, 2022
EP3481838Novel Processes For The Production Of OligonucleotidesGLAXOSMITHKLINEMay 19, 2021
EP2588167Safety Device For A Pre-Filled Syringe And Injection DeviceSANOFI AVENTIS DEUTSCHLANDNov 21, 2018

Explore Janssen Pharmaceutica's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2234617Nov 6, 2024Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters40
EP4005555May 15, 2024Methods For Ensuring Resuspension Of Paliperidone Palmitate Formulations2
EP4025188Jan 10, 2024Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations2
EP4025187Jan 3, 2024Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations2
EP3744326Dec 6, 2023Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters18
EP3609497Oct 12, 2022Combination Therapy For Prostate Cancer3
EP3311374Jul 22, 2020Devices And Methods For Drug Administration And Mixing, And Training Of Proper Techniques Therefor1
EP3280416Apr 22, 2020Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters16
EP3087098Apr 8, 2020Anti-Vista Antibodies And Fragments2
EP2968221Jun 19, 2019Pharmaceutical Composition Of S-Ketamine Hydrochloride4